Profoject Low Dead Space Syringe /Profoject Tuberculin Syringe +3 more— 510(k) K252814

Substantially Equivalent

CMT Health PTE., Ltd.

FDA 510(k) clearance K252814 for Profoject Low Dead Space Syringe /Profoject Tuberculin Syringe +3 more, Substantially Equivalent on 2026-02-19. Applicant: CMT Health PTE., Ltd.. Device class: 2.

Summary

CMT Health's record has four entries, each giving a Profoject Low Dead Space name and a Profoject Tuberculin name: a syringe, a syringe with needle, a syringe with permanent needle, and a safety syringe. They're filed under product code QNQ, low dead space piston syringe, and the record doesn't say how the entries differ beyond their names.

Class II, 21 CFR 880.5860. General Hospital is both the classification panel and the review panel. It came in as a Traditional 510(k).

CMT Health filed from Singapore. Review took 168 calendar days (September 4, 2025 to February 19, 2026), ending in a substantially equivalent decision.

Clearance details

Device name as filed
Profoject Low Dead Space Syringe /Profoject Tuberculin Syringe; Profoject Low Dead Space Syringe with Needle /Profoject Tuberculin Syringe with Needle; Profoject Low Dead Space Syringe with Permanent Needle /Profoject Tuberculin Syringe with Permanent Needle; Profoject Low Dead Space Safety Syringe /Profoject Tuberculin Safety Syringe
Applicant
CMT Health PTE., Ltd.
Product code
Product code QNQ
Device class
Class 2
Regulation
21 CFR 880.5860
Advisory panel
General Hospital
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Singapore, SG
Download summary PDFView on FDA.gov ↗

Recent devices under product code QNQ

view all

More clearances from CMT Health PTE., Ltd.

view all

Data sourced from openFDA. This site is unofficial and independent of the FDA.